December 2012 NYC Hepatitis ABC Newsletter – Click here to view online! http://eepurl.com/sONsn
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
NYS Health Department Defines HCV Experienced Provider
As New York State enters this era of successful HCV treatment, the NYSDOH AIDS Institute has developed criteria for defining those providers qualified to manage and treat patients with HCV infection.
-
#JustB Storytelling Project (Hep B Foundation)
Hep B Foundation will be working on the #justB Storytelling Project to make the real voices of every-day people living with/affected by Hep B heard.
-
Caribbean Hep B & C Workgroup
The NYC Hep C Task Force & Hep B Coalition created a workgroup in 2013 to address hepatitis in the Caribbean communities of NYC.
-
Leaders Call For End To Hep C Treatment Access Crisis
A coalition of leading hepatitis C advocacy organizations and medical experts today called on Health and Human Services Secretary Sylvia Mathews Burwell to take leadership in eliminating harmful and discriminatory barriers to hepatitis C treatment access.
-
NYS Medicaid Adds Epclusa and Viekira XR to Preferred Hep C Med List
The NYS Medicaid Drug Utilization Review Board met on September 15, 2016 and added Epclusa (GT 2 and 3) and Viekira XR to the preferred prescription medication list.
-
US Congress Eases Funding Restrictions for Syringe Access Programs
The US Senate and House of Representatives has eased restrictions on federal funding for elements of syringe access programs
-
Comment! HBV Screening: USPSTF Recommendation Statement
It is estimated that about 700,000 to 1.4 million persons in the United States have chronic HBV infection ( 1, 2). In the United States, persons considered at high risk for HBV infection include persons from high-prevalence countries, persons who...
-
Dear Colleague Letter | Hep B & C Screening & Treatment Guidance 2020 (NYC Health Dept)
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
